Artificial intelligence (AI) has emerged as a transformative tool in pulmonology, revolutionizing diagnostic accuracy and patient outcomes. This study evaluates the application of AI in diagnosing respiratory diseases, highlighting novel algorithms and their integration into clinical workflows. The objective was to assess the efficacy of AI assisted diagnostic tools compared to traditional methods in detecting chronic obstructive pulmonary disease (COPD) and interstitial lung diseases (ILD). A prospective cohort of 200 patients was divided into AI-assisted and conventional diagnostic groups, with outcomes analyzed using validated metrics. The AI-based systems demonstrated significantly higher sensitivity (92.3% vs. 78.5%, p<0.001) and specificity (89.7% vs. 76.2%, p<0.01) in identifying respiratory conditions. Furthermore, diagnostic timelines were reduced by 30% in the AI group (p<0.05). These results suggest that AI offers substantial improvements in diagnostic precision, efficiency, and resource allocation. This study bridges critical gaps in pulmonology diagnostics, paving the way for integrating AI technologies into routine practice. Future research should focus on addressing ethical considerations and enhancing algorithm transparency to bolster clinician and patient trust.